IDO1 and neoplasm: Taken together, AMPK-driven metabolic alterations in MDSCs and CD8+ T cells of IDO−/− mice may cause perturbations in the TME that contribute to the reduced tumor burden, percentages of MDSCs, and percentages of exhausted CD8+ T cells in IDO−/− mice.